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Summary The objective of this study was first to determine whether three slowly growing early-generation murine transplantable tumours,
the T40 fibrosarcoma, Ti 15 mammary carcinoma and T237 lung carcinoma, exhibit patterns of energetics and blood flow during growth that
are different from those of the faster growing RIF-1 fibrosarcoma. Serial measurements were made with 31P-magnetic resonance
spectroscopy (MRS), relating to nutritive blood flow and 2H-magnetic resonance imaging (MRI), which is sensitive to both nutritive and large-
vessel (non-nutritive) flow. All four tumour lines showed a decrease in fiNTP/Pi and pH with growth; however, each line showed a different
pattern of blood flow that did not correlate with the decrease in energetics. Qualitative histological analysis strongly correlated with the 2H-
MRI. Second, their response to 5 mg kg-' hydralazine i.v. was monitored by 31P-MRS. A marked decrease in f3NTP/Pi and pH was observed
in both the RIF-1 fibrosarcoma and the third-generation T115 mammary carcinoma after hydralazine challenge. In contrast, the fourth
generation T40 fibrosarcoma and T237 lung carcinoma showed no change in 31P-MRS parameters. However, a fifth-generation T237 cohort,
which grew approximately three times faster than fourth-generation T237 cohorts, exhibited a significant deterioration in PNTP/Pi and pH in
response to hydralazine. These data are consistent with a decoupling between large-vessel and nutritive blood flow and indicate that early-
generation transplants that have a slow growth rate and vascular tone are more appropriate models of human tumour vasculature than more
rapidly growing, repeatedly transplanted tumours.
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Tumour blood flow is essential for the growth and development of
cancers and can influence the outcome of most forms of non-
surgical therapies. A tumour obtains its nutrition and removes
waste products via nutritive blood flow through the developing
vascular architecture (Vaupel et al, 1989a). In most rodent
tumours, blood flow rates have been shown to decrease as tumour
size increases (Jain and Ward-Hartley, 1984; Jain, 1988). As
tumours grow, the vascular volume and surface area increase more
slowly than the tumour mass, diffusion distances increase and
nutrients must travel further to reach all parts of the tumour.
Subsequently, a point is reached when chronic or diffusion-limited
hypoxia develops in cells, eventually leading to necrosis
(Thomlinson and Gray, 1955).
In vivo nuclear magnetic resonance (NMR) methods provide
non-invasive indicators of tumour biochemistry and physiology
and may be applied to both animal and human tumours in situ. 31p-
magnetic resonance spectroscopy (MRS) has been used to provide
information on tumour bioenergetic status and to monitor tumour
response to therapy. Changes in 31p parameters have often been
explained by changes in tumour perfusion and oxygenation
(Evelhoch et al, 1986; Okunieff et al, 1986; Tozer et al, 1989;
Vaupel et al, 1989b). 2H-magnetic resonance imaging (MRI) ofthe
freely diffusible tracer 2H20 provides an indication of tumour
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vascularity. The measurement of the rate of 2H signal increase in
each pixel creates a map of the spatial blood flow distribution in
the tumour. Previous studies using 2H-MRI on rapidly growing
tumour models have demonstrated that during unperturbed growth
there is a decrease in tumour blood flow (Larcombe-McDouall
et al, 1991; Bumey et al, 1992).
The majority of research on tumours and their vasculature has
been performed in rapidly growing, transplanted animal tumour
models. Differences in the vascular architecture and response to
stimuli have been found between spontaneous and transplantable
tumours (McCredie et al, 1971; Falk, 1982), and between early-
and late-generation transplants (Steel, 1977). Hydralazine chal-
lenge of several transplanted murine tumour models has been
shown to cause a reduction in tumour blood flow (Jirtle, 1988;
Kalmus et al, 1990; Horsman et al, 1992) and a decrease in ener-
getic status and pH, as measured by 3'P-MRS (Okunieffetal, 1988;
Dunn et al, 1989; Bhujwalla et al, 1990a). These results are consis-
tent with a reduction in tumourperfusion giving rise to nutrient and
oxygen deprivation. This effect has been explained as follows:
hydralazine acts directly on the vascular smooth muscle in vessels
of normal tissues, causing vasodilation and an overall decrease in
blood pressure. Tumour blood vessels, which may lack smooth
muscle, basal endothelium or innervation, do not dilate in response
to hydralazine. The net result is aredistribution ofblood flow away
from the tumour and a decrease in tumour perfusion, the so-called
steal effect (Jirtle, 1988). In addition, the high interstitial pressure
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of tumours, coupled with the reduction in systemic blood pressure
after hydralazine, leads to collapse of tumour vessels and a further
decrease in tumour blood flow.
The objective of our experiments was twofold. The first aim was
to determine whether slow-growing early-generation tumours exhibit
characteristic patterns of energetics and tumour blood flow during
unperturbed growth different from those seen in faster growing
tumours. To this end, serial measurements, using both 3'P-MRS and
2H-MRI, were made on three early-generation transplanted murine
tumours and the commonly studied, fast-growing RIF-1 mouse
fibrosarcoma. The relationships between tumour energetic state,
perfusion and growth rate within each line could thus be addressed.
Second, the vascular response of transplanted rodent tumour
models differs in important respects from that of human tumours
(Denekamp, 1992). Primary tumours, which do not always arise at
predictable times, are difficult to study and so a transplantable
rodent tumour that displays a vascular response akin to a clinical
tumour would be valuable. To this end, we have measured the
response of the same panel of tumours to hydralazine by 31P-MRS
to determine whether any differences are correlated with the rate
of tumour growth and vessel development.
MATERIALS AND METHODS
Induction and maintenance of tumours
Three early-generation transplanted murine tumours (kindly
donated by Dr JV Moore, Paterson Institute, Manchester, UK)
designated the T40 fibrosarcoma, T237 lung carcinoma and Tl 15
mammary carcinoma were used. Tumours were grown subcuta-
neously in the right flanks of 7-week-old male or female B6D2
(Fl ) mice (Harlan Olac) by serial passage ofc. 1- to 2-mm3 pieces,
irrigated in growth medium (HAM's F-10 with fetal calf serum)
and implanted using a wide-bored trocar in mice under halothane
(Fluothane, ZENECA) anaesthesia. The basement membrane
matrix, Matrigel (Becton Dickinson), was used for the initial
implantation of the T237 lung carcinoma and Ti 15 mammary
carcinoma, to help establish the line. Each tumour line was reiniti-
ated from frozen stock (i.e. pieces from an earlier generation trans-
plant frozen in growth medium containing 10% dimethyl
sulphoxide), after a maximum of five serial passages had been
performed, in order to maintain stability within the tumour line.
Third-, fourth- and fifth-generation transplants of the T40
fibrosarcoma (T404). the T237 lung carcinoma (T237 ,a, T2374b and
T237 ) and the Ti 15 mammary carcinoma (T1 153), were used. The
subscript denotes the number of passages since the spontaneous
occurrence of the tumour. The RIF-I fibrosarcoma was grown
according to the protocol of Twentyman et al (1980) and desig-
nated 'C, in accordance with this protocol, i.e. second-generation
tumours derived from a fourth in vitro passage.
Study 1: unperturbed growth
Serial NMR was performed on five tumours of each of the four
types. Tumour volume, 3'P-MRS and 2H-MRI measurements were
performed on the same tumours at three time points at intervals
approximating to one volume-doubling time (TD) for each tumour
type. Tumour volume was measured using callipers, assuming an
ellipsoidal shape. Tumour volume-doubling times were obtained
from semilog plots of volume with time in a pilot study in groups
of different tumours ofthe same generation.
31P-MRS
To restrain the mice during the MR experiments, anaesthesia was
induced with an intraperitoneal injection of a combination of
fentanyl citrate (0.315 mg ml-') plus fluanisone (10 mg ml-')
(Hypnorm, Janssen Pharmaceutical) and midazolam (5 mg ml ')
(Hypnovel, Roche). This anaesthetic mixture has been shown to
have a minimal effect on tumour blood flow (Menke and Vaupel,
1988) and 31P-MRS characteristics (Sansom and Wood, 1994).
31P-NMR spectroscopy was performed in a 30-cm horizontal
bore, 4.7-tesla superconducting magnet (Oxford Instruments) at a
resonance frequency of 81 MHz. The mouse was placed on a flask
containing recirculating warm water to keep the core temperature
at 37°C and positioned so that the tumour hung vertically into a
1-cm two-turn surface coil. Data acquisition and processing
were carried out on a Spectroscopy Imaging Systems Corporation
(SISCO, Varian NMR Instruments, Palo Alto. CA, USA) spec-
trometer. Field homogeneity was optimized by shimming on the
water signal for each tumour to a linewidth, typically, of 30-
50 Hz. The position of the tumour was determined by 'H scout
images. Localized 3'P spectra were acquired from cuboidal
volumes of side 0.8 cm using the ISIS pulse sequence (Ordidge et
al, 1986). The voxel was selected to exclude non-tumour tissue.
although in some instances overlying skin was included. Slice
selection used adiabatic (sincos) inversion pulses with a gradient
strength of 7.5 Gauss cm-'. Acquisition used a hard 90° pulse and
a spectral width of 5 kHz with a pulse repetition time of 3 s. Total
acquisition time was 16 min, and 320 transients were averaged for
each free induction decay.
Spectral analysis was performed by the VARPRO time-domain
non-linear least squares method, yielding the following peak para-
meters: areas, frequencies, linewidths and phases (van der Veen
et al, 1988; van den Boogaart et al, 1995). For each VARPRO
analysis the first four data points were excluded from the fit to
eliminate the influence of fast-decaying signals from immobilized
phosphates that cause a baseline hump in the spectra. The data
were fitted assuming contributions from PME, Pi, PDE, PCr and
the three nucleoside triphosphate (NTP) resonances, and peaks
were assumed to be single Lorentzians. The only biochemical and
experimental prior knowledge used was that all peaks were
assumed to have a phase equal to the overall zero-order phase of
the spectrum. No other prior knowledge was assumed. Relative
peak area ratios of the observed phosphates, for example PNTP/P.
and PME/X;P, were then determined. XP was taken to be the sum of
all peaks fitted by VARPRO analysis. Tumour pH was determined
using the VARPRO-derived frequencies for the inorganic phos-
phate (P,) and czNTP resonances (Prichard et al, 1983).
2H-MRI
Deuterium images of 2H,O uptake were acquired at a resonance
frequency of 30.7 MHz immediately after the 3'P-MRS acquisi-
tion, eliminating the need for additional anaesthetic. The mouse
was positioned so that the tumour hung vertically into a 1.5-cm
four-turn solenoid coil, tunable to both 'H and 2H. A 27-gauge
butterfly needle was inserted into one ofthe tail veins for adminis-
tration of the tracer, 'H,O.
After shimming on the IH signal from the tissue water, proton
images were acquired to select an appropriate slice for deuterium
imaging. Deuterium images were obtained from a single 6-mm slice
axially through the tumour, using a steady-state free precession
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(ssfp) gradient echo sequence, with 60 ms repetition time, 10 ms
echo time, 32 phase-encoding steps and 64 transients. The data were
zero-filled and Fourier transformed to provide a matrix size of
64 x 64 with in-plane resolution of0.6 mm.
After a background deuterium image, 100 jt of deuterated
isotonic saline was injected intravenously as a bolus. Four
deuterium images were then acquired, starting at 30, 270, 510 and
750 s after the injection, each image being obtained in 2 min. A
deuterium uptake image was then calculated based on the rate of
increase of signal into each pixel. A simple monoexponential
model was applied to the uptake of2H,O into each pixel as the data
were not acquired until 30 s after injection, thus avoiding any fast
uptake components. Results are presented as the median of all
fitted values, i.e. rate constants (in units of s-') that are propor-
tional to flow for the exponential fit.
Data analysis
For each animal at each time point, four parameters were obtained:
INTP/P, pH, PME/XP and median flow. For each animal and each
parameter, a line was fitted through the values at the three time
points and a slope obtained, thus using each animal as its own
control. A mean slope was calculated from these fitted slopes and
tested for its difference from zero using Student's t-test. A two-
tailed test was used for PME/XP and median flow, whereas for
,BNTP/Pi and pH a one-tailed test was allowed as these parameters
are known to decline with untreated growth in a wide range of
tumour models.
Histology
After the last NMR observation, tumours were excised and placed
in formal saline. Sections were subsequently cut in the same orien-
tation as for the 2H-MRI slice and stained with Ehrlich's haema-
toxylin and eosin, to assess differentiation status, cellularity, viable
tissue and necrosis. Histological analysis consisted of a qualitative
assessment ofthe sections, under the following headings: extensive
necrosis, large central necrosis, patchy necrosis or no necrosis. To
assess the correlation between the vascularpattern suggested by 2H-
MRI images and the nature ofthe tumour vasculature and perfusion
seen in the histological sections, a similar qualitative assessment of
the 2H-MRI images was performed blind from the histology results,
using analogous categories: extensive flow void, large central flow
void, patchy flow voids or no flow voids.
Study 2: response to hydralazine
31P-MRS was performed on 2C4 RIF-1 tumours 22 days post passage
(n = 5), T404 tumours 28 days post passage (ni = 7), and T1 153
tumours 45 days post passage (n = 5). For the T2374 lung carcinoma,
3'P spectra were acquired from a cohort of tumours 93 days post
passage (n = 5) and these tumours were designated T2374a. After
serial passage of one tumour from the T2374a cohort, spectra were
acquired from a subsequent group that developed more rapidly; these
were challenged 33 days post passage (n = 5) and designated T237s.
Another group, designated T2374b were initiated independently and
were the same generation as the T2374a cohort. They were challenged
with hydralazine 107 days post passage (n = 4).
Localized 3'P-MRS was performed as previously described.
31P spectra were acquired in 8-min blocks from the sum of 160
transients. After acquisition of a baseline spectrum, a 5 mg kg-'
bolus injection of hydralazine (Sigma) in saline was administered
via a 27 G tail vein catheter, without disturbing the position of the
mouse in the bore of the magnet and a further four free induction
decays (FIDs) were collected. Control experiments were
performed for each tumour line (n = 5), in which two baseline
spectra were acquired before injection of0.1 ml of a saline vehicle
and five further spectra acquired.
Data analysis
Spectral analysis was performed by VARPRO as before, leading to
estimations ofthe PNTP/P. ratio and tumour pH. Visual inspection
of the acquired data and fitting results was aided by the Fourier
transform ofthe MR spectra after 30 Hz line broadening.
The reproducibility of the 31P-MRS was assessed from the two
pre-saline control measurements. For ,NTP/Pi, the coefficient of
variation (CV) was measured in each of the 20 animals and the
r.m.s. value determined. For pH, the standard deviation was
measured for each of the 20 animals and the r.m.s. value deter-
mined. Tumours in which the PNTP/P, and pH responded to
hydralazine are termed 'deteriorators'. We avoid the use of the
term 'responder' as a deteriorating response of the spectrum is
believed to imply a lack of pharmacological response of the
tumour endothelium to the vasodilator. Deteriorators were defined
as those tumours exhibiting a decline in both 3NTP/P, of 25% and
pH of at least 0.05 units.
Results are presented in the form: mean ± standard error.
Significance testing used the one-sided Student's t-test.
RESULTS
The tumour volume-doubling times for the four tumour lines are
shown in Table 1. Over the volume range studied, growth appeared
exponential and there was no tendency for growth rate to slow in
larger tumours to a Gompertzian pattern. In addition, all growth
curves could be extrapolated back to a nominal initial implantation
volume at day 0 ofjust over 10-2 cm3. All of the early generation
transplants displayed long TD values compared with the rapidly
growing RIF-1 fibrosarcoma. Because of these long TD values,
there was a considerable lag period (defined as the number ofdays
from tumour implantation to a size appropriate for MRS/I) for the
Tl 153 and T2374 lines.
A sensitive index in 31P-MRS of contamination by overlying
skin and muscle is PCr. In our spectra, the PCr peak, where
detected, was generally small and, although small non-tumour
contributions might be expected to the ISIS volumes used, in many
cases these non-tumour contributions would consist mainly of air.
The 3'P spectrum shown in Figure 1 was obtained from a T404
fibrosarcoma of volume 0.26 cm3. Resonances were identified for
PME, Pi, PDE, PCr and y, o and fNTP. Also shown is the recon-
struction after VARPRO analysis, the individual Lorentzians and
the resulting residual signal showing the broad underlying reso-
nances. A 2H uptake image from a T1153 mammary carcinoma is
shown in Figure 2. The 2H uptake patterns were very variable from
one tumour to another: some gave highest flow in the tumour edge
and lower in the centre, whereas others were more heterogeneous.
Table I also shows the mean and standard deviation for
fNTP/Pi pH, PME/XP and median flow for each tumour line from
study 1, measured at the last time point before the tumour volume
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Table 1 Growth characteristics of tumours used in this study
RIF-1 T404 T1153 T2374
Lag time (days) 9 13 31 53
Td (days) 2-3 6-7 7-8 11-12
Volume (cm3) 0.69 + 0.05 0.60 ± 0.05 0.42 ± 0.03 0.69 ± 0.19
,NTP/P 1.25+0.2 1.37+ 0.21 0.75+ 0.13 0.45+ 0.03
pH 7.16+0.03 7.07+0.04 7.06+0.02 6.98+0.04
PME/£P 0.15 0.01 0.13 ± 0.01 0.17 ± 0.02 0.22+ 0.02*
Median flow (s-1) 0.008 ± 0.004 0.007 ± 0.004 0.005 ± 0.003 0.005 ± 0.004
Doubling time (TD) was obtained from interpolation of growth curves from the pilot study. The mean and standard deviation for PNTP/P, pH, PME/XP
and median flow for each tumour line from study 1, measured at the last time point before the tumour volume exceeded 1 cm3, are also shown
(*P < 0.05, ANOVA).
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Figure 1 (A) Localized ISIS 31p spectrum obtained from a T404
fibrosarcoma of volume 0.26 cm3. Acquisition parameters included adiabatic
pulses, a 3-s repetition time, a gradient strength of 7.5 G cm-' and an
acquisition time of 16 min. Resonances are identified for phosphomonoesters
PME, inorganic phosphate Pi, phosphodiesters PDE, phosphocreatine PCr
and y, a and nucleoside triphosphates, (B) VARPRO reconstruction, (C) the
individual Lorentzians and (D) the residual. The estimated peak parameters
were used to calculate the ratiosfINTP/P, and PME/XP, and tumour pH was
obtained from the chemical shift of the P resonance relative to aNTP using
the VARPRO-derived frequencies
exceeded 1 cm3. In the slow-growing T1153 and T2374 lines
fNTP/P, was lower than in the faster growing RIF-1 and T404
tumours. Tumour pH was alkaline or neutral in all four lines. The
T2374 lung carcinoma showed a significantly higherPME/XP ratio
compared with the other lines.
Figure 2 Representative 2H image of 2H2O uptake obtained from a Ti153
mammary carcinoma. White pixels indicate areas of high flow, grey pixels
represent intermediate flow and black pixels areas of low/no tumour blood
flow. This image was classified as having large central necrosis (type 11) in the
2H-MRI/histology analysis
For the early-generation transplants (but not for the RIF-1
fibrosarcoma), the pretreatment PNTP/P, ratio and pH were incon-
sistent between study 1 and study 2. Because of this variability, in
the analysis of study 1 we used each animal as its own control and
fitted a line through the values at the three time points to obtain a
slope. A mean slope was calculated from these fitted slopes and
these are shown in Table 2 with their associated P-values for
progression with tumour volume for all the tumours and each indi-
vidual tumour line. Analysis ofthe data as a whole showed a signif-
icant decrease in PNTP/P. and pH with growth, and all four tumour
models individually showed a significant decrease in INTP/PI with
increasing tumour volume. TumourpH decreased significantly only
in the faster growing RIF-I and T404 fibrosarcomas. In the RIF-1
tumours, median flow varied little over the course of the experi-
ment. In all three early-generation transplants median flow tended
to decrease with tumour volume, although these trends were not
statistically significant. No significant progression ofPME/XP with
increasing volume was found for any ofthe tumour lines studied.
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Table 2 Progression ofINTP/Pi, PME/RP, pH and median flow with increasing volume for all the tumours and each individual tumour line, as indicated by the
sign and magnitude of the calculated mean slope
Parameter All RIF-1 T404 T1153 T2374
PNTP/P, -2.63 -5.80 -2.44 -1.91 -1.22
(0.04) (0.03) (0.01) (0.04) (0.04)
pH -0.25 -0.33 -0.52 -0.03 -0.02
(0.03) (0.02) (0.01) (> 0.1) (> 0.1)
PME/IP 0.04 0.08 0.02 0.002 0.10
(> 0.1) (> 0.1) (>0.1) (> 0.1) (>0.1)
Median flow -9.95 1.31 -68.4 -54.0 -43.1
x 10-4 (> 0.1) (> 0.1) (> 0.1) (0.09) (> 0.1)
Correlation
fNTP/Pi vs pH 0.59 0.57 0.67 0.64 0.67
(0.0001) (0.03) (0.01) (0.01) (0.01)
fINTP/P vs median flow 0.09 0.05 0.26 -0.32 -0.23
(>0.1) (>0.1) (>0.1) (>0.1) (>0.1)
pH vs median flow 0.12 -0.22 0.39 0.01 -0.24
(>0.1) (>0.1) (>0.1) (>0.1) (>0.1)
Its difference from zero was tested for using the t-test and the associated P-value is given in parenthesis. The correlation coefficient rand its associated
P-value in parenthesis for each possible relationship between PNTP/P, pH and median flow are also shown.
Table 3 Growth and response characteristics for the tumours used in study 2.
Tumour Generation Volume (cm3) Lag time AIINTP/P, ApH
RIF-1 fibrosarcoma 2C4 0.41 ± 0.08 22 -72+ 9%* -0.29 ± 0.09*
T1153 mammary carcinoma 3 0.20 ± 0.02 45 -55 + 6%* -0.16 ± 0.04*
T2375 lung carcinoma 5 0.29 ± 0.04 33 -33 + 9%* -0.08 ± 0.03*
T404 fibrosarcoma 4 0.32 ± 0.02 28 -27 ± 16%n.s. -0.15 ± 0.1On.s.
T2374a lung carcinoma 4 0.50 ± 0.11 93 -16 + 20%n.s. +0.03 ± 0.05n.s.
T2374b lung carcinoma 4 0.55 ± 0.03 107 -5+ 6%n.s. +0.01 ± 0.01 n.s.
The table gives the number of passages since the spontaneous occurrence of the tumour, mean tumour volume on the day of measurement, the lag time, i.e.
the number of days from tumour implantation to MRS and the response to hydralazine of the 31P-MR spectra of the four tumour lines 20-28 min after challenge
compared with before challenge. *P< 0.05; n.s. P> 0.05.
To address any relationships between PNTP/P, pH and median
flow, all parameters were plotted against each other for the data as
a whole and for each tumour line to identify any correlation and
tested for deviation from zero. The calculated correlation coeffi-
cients, r, and their associated P-values, are also shown in Table 2.
Significant correlations (P < 0.05) were found forPNTP/P, vs pH
for all the tumours collectively and for each individual tumour
line, implying that decreasing energetic state during unperturbed
growth is coupled with tumour acidification. No significant corre-
lations were observed between PNTP/P. and median flow, or
between pH and median flow.
Histological examination showed a range ofdifferentiation states
across the tumours. The RIF-I fibrosarcoma showed homogeneity
across the sections with fusiform, linear, stream-like cells. The
tissue was poorly differentiated with patchy or no necrosis. Blood
vessels were abundant suggesting a well-vascularized tumour that
is highly angiogenic. The T404 fibrosarcoma showed classical
fusiform cells with long, elongated nuclei. The tissue appeared in
large swirls, typical of a sarcoma, with homogeneity across the
sections and patches of necrosis and was moderately differentiated.
The T2374 lung carcinoma displayed typical rounded cells associ-
ated with a carcinoma. The overall structure was organized, with a
certain amount of stroma and the well-differentiated tissue
appeared in streams. There was apreponderance ofcuffs ofstromal
and fibrous tissue growing around the blood vessels. Sections from
the Tl 153 mammary carcinoma also displayed an organized
structure of rounded cells. In general, small islands of tumour
surrounded by stromal tissue were observed with necrotic foci. The
tissue was poorly differentiated.
Qualitative analysis ofboth the 2H-MR images and the histolog-
ical sections was performed under the following headings: exten-
sive necrosis (type I), large central necrosis (type II), patchy
necrosis (type III) and no necrosis (type IV). The resulting histo-
logical scores were RIF- 1 fibrosarcoma three type III and two type
IV; T40 fibrosarcoma two type I, two type II and one type III;
T115 mammary carcinoma three type II and two type III; T237
lung carcinoma four type II and one type III. The 2H image scores
were RIF-1 fibrosarcoma five type III; T40 fibrosarcoma two type
I, two type IIand one type III; Tl 15 mammary carcinoma five type
II; T237 lung carcinoma one type I, three type II and one type III.
Across all the four tumour lines the grading did not appear to
correlate with growth rate or differentiation state ofthe tumours. A
good correlation could be seen between each independently made
assessment of the histological section and 2H-MR image of each
tumour. Only 5 ofthe 20 tumours showed a mismatch and ofthese
there was only one grade difference.
Table 3 shows the growth characteristics ofall the tumours used
in study 2. All the early-generation transplanted tumours had
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Figure 3 Localized 31p spectra obtained from a RIF-1 tumour (A) before
hydralazine and (B) 28 min after hydralazine (5 mg kg-' i.v.)
slower growth rates than the RIF-1 fibrosarcoma, with both a
longer volume-doubling time and lag time. The mean tumour
volume was similar for each line at the times when they were chal-
lenged with hydralazine. T2374a and T2374b tumours had longer
lag times than the T237s tumours that were transplanted from the
T2374a cohort. For each tumour line, saline-treated tumours were
studied at a similar number of days after passage to those chal-
lenged with hydralazine.
In saline-treated animals, no significant 31P-MRS change was
seen for any tumour line. From successive MR spectra in 20
animals before treatment, the precision of the measurements was
determined: these were 22% for PNTP/P, (r.m.s. CV) and 0.1 pH
units (r.m.s. s.d.) respectively.
Figure 3 shows two 31P spectra acquired from a RIF-1 fibrosar-
coma depicting typical changes in resonance intensity in response
to 5 mg kg-' hydralazine. The energy status deteriorated after treat-
ment, with a large increase in inorganic phosphate (P) and areduc-
tion in NTP. Tumour pH also declined. All of the RIF-1 spectra
deteriorated in response to hydralazine. The time course for this
deterioration is shown in Figure 4A and B. Very different
responses to hydralazine were seen for the early-generation trans-
plants (Table 3). For all Ti 153 and RIF- 1 tumours there was a
pronounced and sustained reduction in both PNTP/P, and pH. For
the T404 tumours only two out of seven animals were classed as
deteriorators: the mean changes in energetics and pH were not
statistically significant.
m. 7.1- _
7.0-
-I1 II
6.9-
-5 5 10 15 20 25 30
Time (min)
Figure 4 Changes observed in (A) fINTP/Pi and (B) pH for the RIF-1
fibrosarcoma (n = 5) and (C) INTP/Pi and (D) pH for the three cohorts of
T237 lung carcinoma in response to 5 mg kg-' hydralazine i.v. T2374al
* (n = 5); T2374b, V (n = 4); T2375, A (n = 5). The arrow indicates the time
of administration of hydralazine/saline. The shaded regions represent control
tumours (mean ± s.e.m.; n = 5 for each line) injected with a saline vehicle.
T2374 generation tumours were used for controls. *Indicates points
significantly different from pretreatment spectra (P < 0.05)
Figure 4C and D shows the changes observed in all three
cohorts of T237 lung carcinomas studied. Statistical significance
at 20-28 min after hydralazine challenge is shown in Table 3. No
significant changes in ONTP/P. and pH were observed for the
T2374a or T2374b lung carcinoma, whereas the faster-developing
T237s transplants showed a significant energetic deterioration.
DISCUSSION
Study 1: unperturbed growth
The sustained median 2H20 uptake we measured in the RIF-1
tumour line during growth is consistent with the histological
analysis that suggested that RIF-1 tumours are well perfused and
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highly angiogenic. A low hypoxic fraction (c. 1-5%) has been
previously measured in RIF-I tumours (Moulder and Rockwell,
1984; Maxwell et al, 1989). Median flow tended to decrease with
tumour growth in all three early-generation transplants. This
decline in tumour perfusion is consistent with the development of
a chaotic and tortuous vascular network that is seen in many
tumours (Warren, 1979; Jain andWard-Hartley, 1984). Histological
examination showed the existence of necrosis in T1153 and this
also is an indication of inadequate perfusion. The median flow in
T2374 was much lower than in RIF-I but did not change signifi-
cantly with growth. The cuffs of tissue around blood vessels, seen
in histological sections of this tumour, also suggest that perfusion
was inadequate to support growing tissue throughout the tumour
volume. The qualitative analysis of the histology showed a good
correlation with the 2H-MRI, despite the difference in slice thick-
ness (6 mm for 2H-MRI compared with ahistological section a few
microns thick) of the two methods. The high proportion of
matching assessments (15 out of20) indicates the potential use of
2H-MRI as a non-invasive indicator of vascular competency and
necrosis within individual tumours.
All four tumour lines showed a significant decline in PNTP/P.
during tumour growth. A significant reduction in PNTP/P, with
increasing tumour volume has been previously found in RIF-1
tumours (Bhujwalla, 1988; Rofstad et al, 1988a), other trans-
planted tumours (Ng et al, 1982; Evanochko et al, 1984; Okunieff
et al, 1986; Vaupel et al, 1989b) and human tumour xenografts
(Rofstad et al, 1988b). A significant decrease of pH with tumour
growth was only found for the faster growing RIF-1 and T404
tumours. A significant correlation ofpH with tumour volume up to
300 mm3 has been previously reported for RIF-1 (Rofstad et al,
1988a), and our data show that this also occurs in larger tumours.
Tumour pH was found to correlate with PNTP/P. for all four
tumour lines, in agreement with previous data for RIF- 1 and FsaII
tumours (Rofstad et al, 1988a; Vaupel et al, 1994). No significant
progression in PME/XP, a parameter shown to increase during
growth of human tumours (Griffiths et al, 1983; Negendank,
1992), was observed for any of the tumour lines studied herein.
Previous reports suggest that the decline in bioenergetic status
with tumour growth is consistent with the tumour vasculature
becoming incapable of providing a nutritive blood supply to the
rapidly expanding tissue (Ng et al, 1982; Evanochko et al, 1984;
Okunieff et al, 1986; Bhujwalla, 1988; Rofstad et al, 1988a;
Vaupel et al, 1989b). This results in a decrease in average cellular
oxygen concentrations and the development of hypoxic tissue. A
general trend towards lower NTP/Pi with decreasing blood flow
has also been reported in the RIF-1 using gaseous wash-out tech-
niques (Lilly et al, 1985; Evelhoch et al, 1986; Bhujwalla et al,
1990b). However, in our work, there was no correlation of
PNTP/P. with blood flow measured by 2H inflow.
This suggests either that the reduction in the level ofhigh-energy
phosphates in our tumours was not due to impaired tumour perfu-
sion, or that the 2H imaging technique measures something in addi-
tion to nutritive blood flow. This wash-in technique may be more
sensitive to flow in large than in small blood vessels because ofthe
sequential filling ofthe vasculature. Wash-outtechniques, however,
are more likely to be weighted towards the flow in the many small
tumour vessels, which are essential for nutritive perfusion and
should thus correlate with energetic status. This interpretation of
our data is consistent with the observation that in all the tumours
there is little correlation between the blood flow in the large vessels
and the energetic status of the tumour.
Tumour growth reflects a fine balance between cell division,
quiescence, cell death and cell migration (Steel, 1977). This
balance may be very different in each of the four tumour lines
studied herein, which had different tissues of origin, histological
patterns and growth rates. Our 2H-MRI wash-in measurements are
unable to distinguish between nutritive and non-nutritive blood
flow, whereas 3IP-MRS reflects only nutritive blood flow. Other
techniques that measure tumour blood flow by gaseous wash-out
would be expected to show similar discrepancies for tumours with
many large and not necessarily nutritive vessels. With growth,
each tumour line showed a different pattern of large-vessel
blood flow but all showed a decrease in 3NTP/Pi, indicating a
decoupling between large-vessel and nutritive blood flow. 31P-MRS
and 2H-MRI revealed no significant differences in energetics and
blood flow between the slow-growing early-generation transplants
and the fast-growing RIF-1 during unperturbed growth. Our data
emphasize the complicated relationship between physiological
parameters such as growth rate, TD, tumour volume, microscopic
perfusion and overall tumour blood flow and also demonstrate the
potential of 2H-MRI to assess tumour necrosis.
Study 2: response to hydralazine
The results presented above show that the various tumours we
studied differ in their response to hydralazine. Our data for the
RIF- 1 fibrosarcoma are consistent with a decrease in tumour
perfusion due to the steal effect, and this is in agreement with
previous reports (Bhujwalla et al, 1990a). The deterioration in
mean INTP/Pi and pH observed for the T1153 mammary carci-
noma demonstrate that this early-generation transplanted tumour
also showed the vascular steal effect. However, the lack of a
significant decrease in mean fNTP/Pi and pH in response to
hydralazine in the slowly growing T2374 lung carcinoma and T404
fibrosarcoma suggests that they did not exhibit the steal phenom-
enon. Such a response has not been observed previously in a trans-
planted rodent tumour, although a similar lack ofvascular steal has
been reported in primary rodent tumours, both spontaneous and
radiation-induced (Field et al, 1991; Wood et al, 1992). More
recently, however, hydralazine has been shown to induce hypoxia
in both transplanted and spontaneous mouse tumours, measured by
31P-MRS and invasive pO2 histography (Horsman et al, 1995;
Nordsmark et al, 1996).
The data suggest that the vasculature of the fourth-generation
T2374 and T404 tumours dilated in response to hydralazine in the
same way as normal vessels. However, the fifth-generation T237s
tumours, which showed the steal effect, apparently had tumour
vasculature that did not dilate in response to hydralazine. The fifth-
generation T237s tumours arose approximately three times more
rapidly than the fourth generation T2374a tumours, which may
have caused the induction of incompletely formed vessels during
tumour angiogenesis. The most likely explanation is that a slower
tumour growth allows the development of fully formed blood
vessels that are able to respond normally. However, it is possible
that the tumours lose some component of the process of angio-
genic stimulation, by clonal selection, as passage number is
increased. Hydralazine is believed to act directly on vascular
smooth muscle, so our data suggest that the vascular smooth
muscle of earlier or more slowly growing transplanted tumours is
more complete than that of faster growing or later transplants.
Differences in response to hydralazine between primary and
transplanted tumours monitored using 31P-MRS have been
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reported. In one study, 5 mg kg-' hydralazine caused an increase in
PI/XP in two transplantable tumours, the SCCVII/Ha tumour and
the mammary carcinoma 16C. However, only 2 out of 12 (17%)
spontaneous tumours showed a similar vascular steal with
hydralazine (Wood et al, 1992). In another report, only 4 out of I 1
(36%) primary radiation-induced murine tumours, with doubling
times of 10-84 days, showed vascular steal with 5 mg kg-'
hydralazine but after transplantation of one of the non-steal
primary tumours into isogeneic mice, 16 out of 17 (94%) trans-
planted tumours, with a doubling time of 4-17 days, showed steal
(Field et al, 1991). These authors suggest that the most likely
explanation for different responses to hydralazine was an effect of
transplantation, causing the vasculature developing in a trans-
planted tumour to be different from that in primaries. Differing
tumour responses to hypoxia may also have some contribution to
the 31P-MRS changes observed. Our data suggest that tumour lag
time and growth rate may be important determinants ofresponse to
vasodilators, as well as transplantation per se.
With respect to tumour vasculature, Rowell et al (1990) showed
that human tumour blood flow increased in response to
hydralazine (0.37-2.86 mg kg-'), suggesting that human tumours
contain vessels with smooth muscle and tone, perhaps as a conse-
quence of their slow growth rate. Our data suggests that early-
transplant tumours with a slow growth rate, such as the T404 and
T2374 tumours used herein, are a more appropriate model of
human tumour vasculature than more rapidly growing, repeatedly
transplanted tumours.
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